MedTrace Logo

Meridian Activation Remedy System for Parkinson's Disease

NCT05621772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-08-05

No results posted yet for this study

Summary

In this study, the investigators aim to evaluate the clinical efficacy and cost-effectiveness of MARS-PD. Conventional, usual care will be used as the comparator because this trial aims to assess the add-on effect of MARS-PD. The investigators hypothesize that the complex therapy will relieve motor and nonmotor symptoms, improve gait performance, and enhance neuroplasticity in PD patients, and will be safe and cost-effective.

Conditions

  • Parkinson Disease

Interventions

OTHER

Meridian Activation Remedy System for Parkinson's Disease (MARS-PD)

MARS-PD is a complex therapy developed by researchers to enhance the synergistic effects of acupuncture and exercise.

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    lead OTHER_GOV

Principal Investigators

  • Ho Ryong Yoo, Prof. Dr. · Daejeon University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-08
Primary Completion
2025-07-03
Completion
2025-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621772 on ClinicalTrials.gov